Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Payables (2016 - 2025)

National Research's Payables history spans 16 years, with the latest figure at $8.8 million for Q4 2025.

  • For Q4 2025, Payables rose 0.63% year-over-year to $8.8 million; the TTM value through Dec 2025 reached $8.8 million, up 0.63%, while the annual FY2025 figure was $8.8 million, 0.63% up from the prior year.
  • Payables for Q4 2025 was $8.8 million at National Research, up from $7.8 million in the prior quarter.
  • Across five years, Payables topped out at $12.8 million in Q1 2024 and bottomed at $5.1 million in Q1 2021.
  • The 5-year median for Payables is $9.0 million (2023), against an average of $9.4 million.
  • The largest annual shift saw Payables plummeted 51.34% in 2021 before it soared 124.01% in 2022.
  • A 5-year view of Payables shows it stood at $9.3 million in 2021, then dropped by 7.18% to $8.6 million in 2022, then skyrocketed by 32.8% to $11.4 million in 2023, then dropped by 23.36% to $8.8 million in 2024, then grew by 0.63% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Payables are $8.8 million (Q4 2025), $7.8 million (Q3 2025), and $7.9 million (Q2 2025).